ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...
Yahoo Finance on MSN15d
Oracle debuts new AI agents as artificial intelligence war enters next battleOracle’s announcement comes after the company’s chairman, Larry Ellison, joined OpenAI CEO Sam Altman and SoftBank CEO Masayoshi Son to announce their joint Stargate Project. The venture seeks to ...
which uses Google Cloud tools including Vertex AI and advanced large language models, will analyze video footage of each run and capture data on metrics ranging from amplitude to trick difficulty ...
EST Vertex Pharmaceuticals (VRTX) files automatic mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the ...
Biotechnology company Vertex Pharmaceuticals (VRTX) reported mixed results for the fourth quarter of 2024. While revenue surpassed analyst ...
Shares of Vertex Pharmaceuticals Inc. VRTX slipped 3.14% to $455.22 Tuesday, on what proved to be an all-around favorable ...
This was the stock's second consecutive day of losses.
Tuesday, Cantor Fitzgerald reaffirmed its Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a consistent price target of $480.00. According to InvestingPro data ...
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback